Milwaukee – Foley & Lardner LLP announced that the National Institutes of Health (NIH) awarded a $208 million contract to the firm for Intellectual Property services for up to 10 years. Beginning this month, the firm will be responsible for performing contested proceedings work in the areas of biotechnology patents and mechanical/electrical/software patents over the life of the contract.
The NIH, a part of the United States Health and Human Services, is the primary Federal agency for conducting and supporting medical research. It is composed of 27 Institutes and Centers that focus on a broad array of medical research programs including cancer, diabetes, mental health and heart disease.
Foley Intellectual Property attorneys in the firm’s Boston, San Diego/Del Mar, Madison and Washington, D.C. offices will be working on this contract. They will support the NIH Office of
Technology Transfer responsible for overseeing the wide range of NIH and Food and Drug Administration (FDA) discoveries, inventions and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.